18 Feb 2021 --- Spain-based Noventure has signed an exclusivity agreement with Azur – a division of Solutex – for the licensing rights of EPA3G, a patented emulsion of high-purity eicosapentaenoic acid (EPA) in over 50 countries. The supplement boasts 3 g of pure EPA in a single dose and comes in a drinkable single sachet format.
